Dr. Matt Boente MD is an experienced physician specializing in Obstetrics, Gynecology, and Gynecologic Oncology.  He is currently based in San Francisco, CA.  Dr. Boente was a Galloway Fellow at the Department of Surgery at Memorial-Sloan Kettering Cancer Center in New York.  He was also a fellow at the Division of Gynecologic Oncology at Duke University in Durham, North Carolina.  

From 2017 – 2018, Dr. Matt Boente MD worked with Genentech, Inc. and led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.   With a career spanning years, his practice was recognized by different publications, including Minneapolis-St. Paul Magazine’s Top Doctors Award from 2002 – 2015, Minnesota Monthly’s Best Doctors for Women Award from 2002 – 2015, and Philadelphia Magazine’s Top Doctors Award from 1994 – 2000. In 2012, he received the National Cancer Institute Gold Certificate of Excellence Award.